九典制药：销售费用端优化明显，业绩保持稳定增长
Hunan Jiudian Pharmaceutical (300705) 华西证券·2024-08-28 06:03证券研究报告|公司点评报告 [Table_Date] 2024 年 8 月 27 日 [Table_Title] 销售费用端优化明显，业绩保持稳定增长 | --- | --- | --- | |----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------- ...